Gossamer Bio, Inc. (GOSS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 16.95M | 13.8M | 13.29M | 11.49M | 9.89M | 9.38M | 9.48M | 95.84M | 0 | 0 | 0 | 0 |
| Revenue Growth % | 71.45% | 47.13% | 40.23% | -88.01% | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 232K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 1.37% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 16.72M | 13.8M | 13.29M | 11.49M | 9.89M | 9.38M | 9.48M | 95.84M | 0 | 0 | 0 | 0 |
| Gross Margin % | 98.63% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | - | - | - | - |
| Gross Profit Growth % | 69.11% | 47.13% | 40.23% | -88.01% | - | - | - | - | - | - | - | - |
| Operating Expenses | 61.59M | 59.84M | 62.41M | 50.25M | 46.7M | 45.51M | 43.4M | 43.76M | 41.96M | 49.03M | 40.49M | 46.3M |
| OpEx % of Revenue | 363.25% | 433.65% | 469.44% | 437.41% | 472.23% | 485.2% | 457.8% | 45.65% | - | - | - | - |
| Selling, General & Admin | 18.75M | 10.9M | 9.39M | 8.68M | 8.66M | 9.39M | 8.5M | 8.67M | 9.57M | 9.06M | 9.29M | 9.98M |
| SG&A % of Revenue | 110.56% | 79.02% | 70.63% | 75.54% | 87.55% | 100.17% | 89.68% | 9.05% | - | - | - | - |
| Research & Development | 43.07M | 48.94M | 53.02M | 41.58M | 38.04M | 36.11M | 34.9M | 35.09M | 32.39M | 29.97M | 31.2M | 36.31M |
| R&D % of Revenue | 254.03% | 354.63% | 398.81% | 361.87% | 384.68% | 385.03% | 368.11% | 36.61% | - | - | - | - |
| Other Operating Expenses | -227K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 15K |
| Operating Income | -44.87M | -46.04M | -49.11M | -38.77M | -36.81M | -36.13M | -33.92M | 52.09M | -41.96M | -49.03M | -40.49M | -46.3M |
| Operating Margin % | -264.62% | -333.65% | -369.44% | -337.41% | -372.23% | -385.2% | -357.8% | 54.35% | - | - | - | - |
| Operating Income Growth % | -21.89% | -27.44% | -44.8% | -174.42% | 12.27% | 26.31% | 16.23% | 212.5% | 12.48% | 9.81% | 27.72% | 14.06% |
| EBITDA | -44.63M | -45.81M | -49.11M | -38.55M | -36.47M | -35.05M | -32.82M | 53.08M | -40.97M | -48.02M | -39.4M | -45.15M |
| EBITDA Margin % | -263.25% | -332% | -369.4% | -335.56% | -368.77% | -373.74% | -346.21% | 55.38% | - | - | - | - |
| EBITDA Growth % | -22.39% | -30.7% | -49.62% | -172.63% | 11% | 27% | 16.7% | 217.56% | 12.45% | 9.79% | 28.24% | 14.45% |
| D&A (Non-Cash Add-back) | 232K | 227K | 6K | 213K | 342K | 1.07M | 1.1M | 992K | 986K | 1.01M | 1.09M | 1.15M |
| EBIT | -44.87M | -44.58M | -45.47M | -35.53M | -33.89M | -32.7M | -29.2M | 56.58M | -38.8M | -44.91M | -36.66M | -39.07M |
| Net Interest Income | -2.4M | -2.3M | -2.06M | -2.2M | -2.45M | -2.74M | -2.3M | -1.17M | -2.79M | -2.93M | -2.94M | -2.73M |
| Interest Income | 354K | 447K | 687K | 542K | 294K | 0 | 430K | 1.75M | 344K | 310K | 405K | 695K |
| Interest Expense | 2.75M | 2.75M | 2.75M | 2.74M | 2.75M | 2.74M | 2.73M | 2.92M | 3.13M | 3.24M | 3.34M | 3.43M |
| Other Income/Expense | -1.8M | -1.29M | 893K | 492K | 172K | 689K | 1.98M | 1.58M | 31K | 879K | 482K | 3.8M |
| Pretax Income | -46.66M | -47.33M | -48.22M | -38.27M | -36.64M | -35.44M | -31.93M | 53.67M | -41.93M | -48.15M | -40.01M | -42.5M |
| Pretax Margin % | -275.22% | -342.97% | -362.73% | -333.13% | -370.49% | -377.85% | -336.87% | 56% | - | - | - | - |
| Income Tax | 0 | -88K | 0 | 0 | 0 | -2.41M | -1.13M | 4.43M | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0.19% | 0% | 0% | 0% | 6.8% | 3.54% | 8.26% | 0% | 0% | 0% | 0% |
| Net Income | -46.66M | -47.24M | -48.22M | -38.27M | -36.64M | -33.03M | -30.8M | 49.23M | -41.93M | -48.15M | -40.01M | -42.5M |
| Net Margin % | -275.22% | -342.33% | -362.73% | -333.13% | -370.49% | -352.16% | -324.93% | 51.37% | - | - | - | - |
| Net Income Growth % | -27.37% | -43.02% | -56.55% | -177.74% | 12.62% | 31.4% | 23.01% | 215.85% | 14.72% | 13.66% | 32.6% | 24.74% |
| Net Income (Continuing) | -46.66M | -47.24M | -48.22M | -38.27M | -36.64M | -33.03M | -30.8M | 49.23M | -41.93M | -48.15M | -40.01M | -42.5M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.20 | -0.21 | -0.21 | -0.17 | -0.16 | -0.15 | -0.14 | 0.21 | -0.19 | -0.21 | -0.21 | -0.45 |
| EPS Growth % | -25% | -40% | -50% | -180.95% | 15.79% | 28.57% | 33.33% | 146.67% | 63.46% | 65.57% | 69.57% | 41.56% |
| EPS (Basic) | -0.20 | -0.21 | -0.21 | -0.17 | -0.16 | -0.15 | -0.14 | 0.22 | -0.19 | -0.21 | -0.21 | -0.45 |
| Diluted Shares Outstanding | 234.14M | 226.6M | 227.98M | 227.28M | 226.82M | 226.6M | 226.35M | 238.54M | 225.74M | 225.41M | 192.88M | 95.45M |
| Basic Shares Outstanding | 234.14M | 226.6M | 227.98M | 227.28M | 226.82M | 226.6M | 226.35M | 226.22M | 225.74M | 225.41M | 192.88M | 95.45M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |